The National Cancer Policy Forum held a public workshop on February 12-13, 2018 to examine strategies to ensure that patients have access to appropriate oncologic pathology and imaging expertise and technologies to inform their cancer diagnosis, treatment planning, assessment of treatment response, and oncologic surveillance.
Potential strategies that were explored included opportunities to develop and maintain a workforce with oncologic imaging and pathology competencies and the role of new technologies and models of care to improve access to this expertise. The workshop featured invited presentations and panel discussions on topics such as:
•Training needs for clinicians who interpret pathology and imaging results for patients with cancer.
•Models of care that can improve patient access to cancer specialists in pathology and radiology and implications on patient outcomes and clinical practice.
•Opportunities to enhance collaboration among pathologists, radiologists, and oncologists to improve diagnostic testing and treatment decision-making for patients with cancer.
•Challenges and opportunities for technologies to facilitate improved diagnostic decision-making among specialists and generalists.
•Potential role of new advances in imaging and pathology technologies to improve decision making for patients with cancer.
Confirmed Moderators, Speakers, and Panelists
Amy Abernethy, Flatiron Health
Ellen Baker, The University of Texas MD Anderson Cancer Center, Project ECHO
Michael Becich, The University of Pittsburgh School of Medicine
Otis Brawley, American Cancer Society
James Brink, Massachusetts General Hospital and the American College of Radiology
Boris Brkljacic, European Society of Radiology
Christopher Cogle, University of Florida/Leukemia & Lymphoma Society
Michael Cohen, Wake Forest School of Medicine
John Cox, Parkland Health and Hospital System/UT Southwestern
Kojo Elenitoba-Johnson, University of Pennsylvania Perelman School of Medicine and the Association for Molecular Pathology
Fiona Fennessy, Dana-Farber Cancer Institute/Harvard Medical School
Richard Friedberg, University of Massachusetts Medical School – Baystate
Lawrence “Rusty” Hofmann, Stanford School of Medicine and Grand Rounds
Hedvig Hricak, Memorial Sloan Kettering Cancer Center
Ramin Khorasani, Brigham and Women's Hospital and Harvard Medical School
Ronald Kline, Centers for Medicare & Medicaid Services
Curtis Langlotz, Stanford University
David Larson, Stanford University
Jordan Laser, Northwell Health and the Association for Molecular Pathology
Ritu Nayar, Northwestern University
Gregory Riely, Memorial Sloan Kettering Cancer Center
William Sause, Intermountain Healthcare
Richard L. Schilsky, American Society of Clinical Oncology
Brian Shirts, University of Washington
Dana Siegal, CRICO Strategies
Patty Spears, UNC Lineberger Comprehensive Cancer Center
William Stead, Vanderbilt University Medical Center
Bruce Stewart, Massachusetts Radiological Society
Brent Wagner, American Board of Radiology
Jeremy Warner, Vanderbilt University Medical Center
Mary Zutter, Vanderbilt University Medical Center
Planning Committee Members
Hedvig Hricak (chair), Memorial Sloan Kettering Cancer Center
James Brink, Massachusetts General Hospital and the American College of Radiology
Christopher Cogle, University of Florida/Leukemia & Lymphoma Society
Michael Cohen, Wake Forest School of Medicine
Michael Dill, Association of American Medical Colleges
Kojo Elenitoba-Johnson, University of Pennsylvania Perelman School of Medicine and the Association for Molecular Pathology
Curtis Langlotz, Stanford University
Richard L. Schilsky, American Society of Clinical Oncology
William Stead, Vanderbilt University Medical Center
Robert Winn, University of Illinois Health Cancer Center/University of Illinois at Chicago
Wendy Woodward, The University of Texas MD Anderson Cancer Center
For videos of this event, please visit:
https://www.youtube.com/playlist?list=PLGTMA6QkejfiwIKyKEwHn1NgAair414g9